Paclitaxel and gemcitabine, as first-line chemotherapy, combined with trastuzumab in patients with advanced breast cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples